Targeting Oncogenic BRAF: Past, Present, and Future.

Cancers (Basel) · 2019 · PMC6721448 · PMID 31426419

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

reported that in treatment-naïve melanoma, baseline PTEN loss/mutation showed a trend for shorter median PFS—18.3 weeks (PTEN mutant) versus 32.1 weeks (PTEN wild type) [ 86 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.